The proprotein convertase subtilisin/kexin FurinA regulates zebrafish host response against Mycobacterium marinum

Infection and Immunity

Volumn 83, Issue 4, 2015, Pages 1431-1442

  Ojanen, Markus J T ^a   Turpeinen, Hannu ^a   Cordova, Zuzet M ^a   Hammarén, Milka M ^a   Harjula, Sanna Kaisa E ^a   Parikka, Mataleena ^a   Rämet, Mika ^a,b,c,d   Pesu, Marko ^a,b,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; FURIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17A F3; LYMPHOTOXIN; TRANSCRIPTION FACTOR FOXP3A; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD3 ANTIGEN; CD3 ANTIGEN, ZETA CHAIN; FURINA PROTEIN, ZEBRAFISH; MESSENGER RNA; MORPHOLINO OLIGONUCLEOTIDE; SERINE PROTEINASE; SUBTILISIN; TUMOR NECROSIS FACTOR; ZEBRAFISH PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; FLOW CYTOMETRY; FURINA GENE; GENE; GENE EXPRESSION; GENE SILENCING; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIETIC CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; MYCOBACTERIUM MARINUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ZEBRA FISH; ANIMAL; ATYPICAL MYCOBACTERIOSIS; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; EMBRYOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; TUBERCULOSIS;

ANIMALS; ANTIGENS, CD3; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; GRANULOCYTES; IMMUNITY, INNATE; INTERLEUKIN-17; LYMPHOTOXIN-ALPHA; MORPHOLINOS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM MARINUM; PROPROTEIN CONVERTASES; RNA, MESSENGER; SUBTILISIN; TH1 CELLS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84925356200     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03135-14     Document Type: Article

References (67)

1. Butler D. 2000. New fronts in an old war. Nature 406:670-672. http://dx.doi.org/10.1038/35021291.
2. Zumla A, Raviglione M, Hafner R, von Reyn CF. 2013. Tuberculosis. N Engl J Med 368:745-755. http://dx.doi.org/10.1056/NEJMra1200894.
3. North R, Jung Y. 2004. Immunity to tuberculosis. Annu Rev Immunol 22:599-623. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104635.
4. Philips JA, Ernst JD. 2012. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 7:353-384. http://dx.doi.org/10.1146/annurev-pathol-011811-132458.
5. Cooper AM, Mayer-Barber KD, Sher A. 2011. Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4:252-260. http://dx.doi.org/10.1038/mi.2011.13.
6. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254. http://dx.doi.org/10.1084/jem.178.6.2249.
7. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243-2247. http://dx.doi.org/10.1084/jem.178.6.2243.
8. Cooper AM, Magram J, Ferrante J, Orme IM. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186: 39-45. http://dx.doi.org/10.1084/jem.186.1.39.
9. Seidah NG, Prat A. 2012. The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov 11:367-383. http://dx.doi.org/10.1038/nrd3699.
10. Artenstein AW, Opal SM. 2011. Proprotein convertases in health and disease. N Engl J Med 365:2507-2518. http://dx.doi.org/10.1056/NEJM ra1106700.
11. Fuller RS, Brake AJ, Thorner J. 1989. Intracellular targeting and structural conservation of a prohormone-processing endoprotease. Science 246:482-486. http://dx.doi.org/10.1126/science.2683070.
12. Thomas G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3:753-766. http://dx.doi.org/10.1038/nrm934.
13. Remacle AG, Rozanov DV, Fugere M, Day R, Strongin AY. 2006. Furin regulates the intracellular activation and the uptake rate of cell surfaceassociated MT1-MMP. Oncogene 25:5648-5655. http://dx.doi.org/10.1038/sj.onc.1209572.
14. Turpeinen H, Raitoharju E, Oksanen A, Oksala N, Levula M, Lyytikainen LP, Jarvinen O, Creemers JW, Kahonen M, Laaksonen R, Pelto-Huikko M, Lehtimaki T, Pesu M. 2011. Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. Atherosclerosis 219:799-806. http://dx.doi.org/10.1016/j.atherosclerosis.2011.08.011.
15. Pesu M, Muul L, Kanno Y, O'Shea JJ. 2006. Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. Blood 108:983-985. http://dx.doi.org/10.1182/blood-2005-09-3824.
16. Meissner F, Scheltema RA, Mollenkopf HJ, Mann M. 2013. Direct proteomic quantification of the secretome of activated immune cells. Science 340:475-478. http://dx.doi.org/10.1126/science.1232578.
17. Lund RJ, Chen Z, Scheinin J, Lahesmaa R. 2004. Early target genes of IL-12 and STAT4 signaling in th cells. J Immunol 172:6775-6782. http://dx.doi.org/10.4049/jimmunol.172.11.6775.
18. Pesu M, Watford WT, Wei L, Xu L, Fuss I, Strober W, Andersson J, Shevach EM, Quezado M, Bouladoux N, Roebroek A, Belkaid Y, Creemers J, O'Shea JJ. 2008. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455:246-250. http://dx.doi.org/10.1038/nature07210.
19. Lin H, Ah Kioon MD, Lalou C, Larghero J, Launay JM, Khatib AM, Cohen-Solal M. 2012. Protective role of systemic furin in immune response-induced arthritis. Arthritis Rheum 64:2878-2886. http://dx.doi.org/10.1002/art.34523.
20. Roebroek AJ, Umans L, Pauli IG, Robertson EJ, van Leuven F, Van de Ven WJ, Constam DB. 1998. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. Development 125: 4863-4876.
21. Meeker ND, Trede NS. 2008. Immunology and zebrafish: spawning new models of human disease. Dev Comp Immunol 32:745-757. http://dx.doi.org/10.1016/j.dci.2007.11.011.
22. Sullivan C, Kim CH. 2008. Zebrafish as a model for infectious disease and immune function. Fish Shellfish Immunol 25:341-350. http://dx.doi.org/10.1016/j.fsi.2008.05.005.
23. Lohi O, Parikka M, Ramet M. 2013. The zebrafish as a model for paediatric diseases. Acta Paediatr 102:104-110. http://dx.doi.org/10.1111/j.1651-2227.2012.02835.x.
24. Zhu LY, Nie L, Zhu G, Xiang LX, Shao JZ. 2013. Advances in research of fish immune-relevant genes: a comparative overview of innate and adaptive immunity in teleosts. Dev Comp Immunol 39:39-62. http://dx.doi.org/10.1016/j.dci.2012.04.001.
25. Parikka M, Hammaren MM, Harjula SK, Halfpenny NJ, Oksanen KE, Lahtinen MJ, Pajula ET, Iivanainen A, Pesu M, Ramet M. 2012. Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish. PLoS Pathog 8:e1002944. http://dx.doi.org/10.1371/journal.ppat.1002944.
26. Stamm LM, Brown EJ. 2004. Mycobacterium marinum: the generalization and specialization of a pathogenic Mycobacterium. Microbes Infect 6:1418-1428. http://dx.doi.org/10.1016/j.micinf.2004.10.003.
27. Carvalho R, de Sonneville J, Stockhammer OW, Savage ND, Veneman WJ, Ottenhoff TH, Dirks RP, Meijer AH, Spaink HP. 2011. A highthroughput screen for tuberculosis progression. PLoS One 6:e16779. http://dx.doi.org/10.1371/journal.pone.0016779.
28. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. 2002. Real-time visualization of Mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17:693-702. http://dx.doi.org/10.1016/S1074-7613(02)00475-2.
29. Prouty MG, Correa NE, Barker LP, Jagadeeswaran P, Klose KE. 2003. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS Microbiol Lett 225:177-182. http://dx.doi.org/10.1016/S0378-1097(03)00446-4.
30. Walker MB, Miller CT, Coffin Talbot J, Stock DW, Kimmel CB. 2006. Zebrafish furin mutants reveal intricacies in regulating Endothelin1 signaling in craniofacial patterning. Dev Biol 295:194-205. http://dx.doi.org/10.1016/j.ydbio.2006.03.028.
31. Langenau DM, Ferrando AA, Traver D, Kutok JL, Hezel JP, Kanki JP, Zon LI, Look AT, Trede NS. 2004. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci U S A 101:7369-7374. http://dx.doi.org/10.1073/pnas.0402248101.
32. Turpeinen H, Oksanen A, Kivinen V, Kukkurainen S, Uusimaki A, Ramet M, Parikka M, Hytonen VP, Nykter M, Pesu M. 2013. Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a). J Biol Chem 288:36610-36623. http://dx.doi.org/10.1074/jbc.M113.453183.
33. Benard EL, van der Sar AM, Ellett F, Lieschke GJ, Spaink HP, Meijer AH. 2012. Infection of zebrafish embryos with intracellular bacterial pathogens. J Vis Exp 61:3781. http://dx.doi.org/10.3791/3781.
34. Oksanen KE, Halfpenny NJ, Sherwood E, Harjula SK, Hammaren MM, Ahava MJ, Pajula ET, Lahtinen MJ, Parikka M, Ramet M. 2013. An adult zebrafish model for preclinical tuberculosis vaccine development. Vaccine 31:5202-5209. http://dx.doi.org/10.1016/j.vaccine.2013.08.093.
35. Tuominen VJ, Isola J. 2009. The application of JPEG2000 in virtual microscopy. J Digital Imaging 22:250-258. http://dx.doi.org/10.1007/s10278-007-9090-z.
36. Tang R, Dodd A, Lai D, McNabb WC, Love DR. 2007. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin 39:384-390. http://dx.doi.org/10.1111/j.1745-7270.2007.00283.x.
37. Ellett F, Lieschke GJ. 2010. Zebrafish as a model for vertebrate hematopoiesis. Curr Opin Pharmacol 10:563-570. http://dx.doi.org/10.1016/j.coph.2010.05.004.
38. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG. 2001. Evidence that furin is an authentic transforming growth factorbeta1-converting enzyme. Am J Pathol 158:305-316. http://dx.doi.org/10.1016/S0002-9440(10)63970-3.
39. Seidah NG, Mayer G, Zaid A, Rousselet E, Nassoury N, Poirier S, Essalmani R, Prat A. 2008. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol 40:1111-1125. http://dx.doi.org/10.1016/j.biocel.2008.01.030.
40. Nasevicius A, Ekker SC. 2000. Effective targeted gene "knockdown" in zebrafish. Nat Genet 26:216-220. http://dx.doi.org/10.1038/79951.
41. Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S. 2012. Mycobacterium tuberculosis: immune evasion, latency, and reactivation. Immunobiology 217:363-374. http://dx.doi.org/10.1016/j.imbio.2011.07.008.
42. Velez DR, Wejse C, Stryjewski ME, Abbate E, Hulme WF, Myers JL, Estevan R, Patillo SG, Olesen R, Tacconelli A, Sirugo G, Gilbert JR, Hamilton CD, Scott WK. 2010. Variants in Toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet 127:65-73. http://dx.doi.org/10.1007/s00439-009-0741-7.
43. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M. 2012. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335:225-228. http://dx.doi.org/10.1126/science.1214400.
44. Hipp M, Shepherd D, Gileadi U, Aichinger M, Kessler B, Edelmann M, Essalmani R, Seidah N, Reis e Sousa C, Cerundolo V. 2013. Processing of human Toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity 39:711-721. http://dx.doi.org/10.1016/j.immuni.2013.09.004.
45. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8:265-277. http://dx.doi.org/10.1023/A:1008942828960.
46. Taverniti V, Stuknyte M, Minuzzo M, Arioli S, De Noni I, Scabiosi C, Cordova ZM, Junttila I, Hamalainen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S. 2013. S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Appl Environ Microbiol 79:1221-1231. http://dx.doi.org/10.1128/AEM.03056-12.
47. Turpeinen H, Ortutay Z, Pesu M. 2013. Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics 14: 453-467. http://dx.doi.org/10.2174/1389202911314050010.
48. Refaie S, Gagnon S, Gagnon H, Desjardins R, D'Anjou F, D'Orleans-Juste P, Zhu X, Steiner DF, Seidah NG, Lazure C, Salzet M, Day R. 2012. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion. J Biol Chem 287:14703-14717. http://dx.doi.org/10.1074/jbc.M111.323220.
49. Renshaw SA, Trede NS. 2012. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech 5:38-47. http://dx.doi.org/10.1242/dmm.007138.
50. Lin AF, Xiang LX, Wang QL, Dong WR, Gong YF, Shao JZ. 2009. The DC-SIGN of zebrafish: insights into the existence of a CD209 homologue in a lower vertebrate and its involvement in adaptive immunity. J Immunol 183:7398-7410. http://dx.doi.org/10.4049/jimmunol.0803955.
51. Bennett CM, Kanki JP, Rhodes J, Liu TX, Paw BH, Kieran MW, Langenau DM, Delahaye-Brown A, Zon LI, Fleming MD, Look AT. 2001. Myelopoiesis in the zebrafish, Danio rerio. Blood 98:643-651. http://dx.doi.org/10.1182/blood.V98.3.643.
52. Balla KM, Lugo-Villarino G, Spitsbergen JM, Stachura DL, Hu Y, Banuelos K, Romo-Fewell O, Aroian RV, Traver D. 2010. Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants. Blood 116:3944-3954. http://dx.doi.org/10.1182/blood-2010-03-267419.
53. Dobson JT, Seibert J, Teh EM, Da'as S, Fraser RB, Paw BH, Lin TJ, Berman JN. 2008. Carboxypeptidase A5 identifies a novel mast cell lineage in the zebrafish providing new insight into mast cell fate determination. Blood 112:2969-2972. http://dx.doi.org/10.1182/blood-2008-03-145011.
54. Yoder JA, Turner PM, Wright PD, Wittamer V, Bertrand JY, Traver D, Litman GW. 2010. Developmental and tissue-specific expression of NITRs. Immunogenetics 62:117-122. http://dx.doi.org/10.1007/s00251-009-0416-5.
55. Ward AC, Loeb DM, Soede-Bobok AA, Touw IP, Friedman AD. 2000. Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 14:973-990. http://dx.doi.org/10.1038/sj.leu.2401808.
56. Chen C, Huang X, Atakilit A, Zhu Q, Corey SJ, Sheppard D. 2006. The integrin α9β1 contributes to granulopoiesis by enhancing granulocyte colony-stimulating factor receptor signaling. Immunity 25:895-906. http://dx.doi.org/10.1016/j.immuni.2006.10.013.
57. Tan-Pertel HT, Walker L, Browning D, Miyamoto A, Weinmaster G, Gasson JC. 2000. Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J Immunol 165:4428-4436. http://dx.doi.org/10.4049/jimmunol.165.8.4428.
58. Horiuchi K, Kimura T, Miyamoto T, Miyamoto K, Akiyama H, Takaishi H, Morioka H, Nakamura T, Okada Y, Blobel CP, Toyama Y. 2009. Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 182:2093-2101. http://dx.doi.org/10.4049/jimmunol.0802491.
59. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB. 2007. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204:2159-2169. http://dx.doi.org/10.1084/jem.20062105.
60. + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123:50-59. http://dx.doi.org/10.1016/j.clim.2006.11.009.
61. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369-377. http://dx.doi.org/10.1038/nrm2146.
62. Hammaren MM, Oksanen KE, Nisula HM, Luukinen BV, Pesu M, Ramet M, Parikka M. 2014. Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish. PLoS Pathog 10:e1004190. http://dx.doi.org/10.1371/journal.ppat.1004190.
63. Clay H, Volkman HE, Ramakrishnan L. 2008. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29:283-294. http://dx.doi.org/10.1016/j.immuni.2008.06.011.
64. Garcia-Elorriaga G, Carrillo-Montes G, Mendoza-Aguilar M, Gonzalez-Bonilla C. 2010. Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. Inflammation 33:267-275. http://dx.doi.org/10.1007/s10753-010-9181-8.
65. Roca FJ, Ramakrishnan L. 2013. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153:521-534. http://dx.doi.org/10.1016/j.cell.2013.03.022.
66. Kumar A, Singh S, Ahirwar SK, Nath G. 2014. Proteomics-based identification of plasma proteins and their association with the host-pathogen interaction in chronic typhoid carriers. Int J Infect Dis 19:59-66. http://dx.doi.org/10.1016/j.ijid.2013.10.008.
67. Becker GL, Lu Y, Hardes K, Strehlow B, Levesque C, Lindberg I, Sandvig K, Bakowsky U, Day R, Garten W, Steinmetzer T. 2012. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. J Biol Chem 287:21992-22003. http://dx.doi.org/10.1074/jbc.M111.332643.